Free Trial

10 Best Small Cap Stocks to Buy Now - 5 of 10

 
 

Oruka Therapeutics (NASDAQ:ORKA)

Consensus Rating
Buy
Rating Score
3.3
Ratings Breakdown
6 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$41.25 (65.0% Upside)

About Oruka Therapeutics

Oruka Therapeutics logoARCA biopharma, Inc, a biopharmaceutical company, develops genetically-targeted therapies for heart failure and cardiovascular diseases. It is positioned to bring personalized therapies for the treatment of cardiovascular disease, through the use of genetics. Complementing the Company's cardiovascular science, ARCA's management team has significant experience in developing and commercializing cardiovascular products. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
9/17/2024Leerink PartnrsUpgradeStrong-Buy
9/17/2024Leerink PartnersInitiated CoverageOutperform$44.00
9/16/2024Lifesci CapitalInitiated CoverageOutperform$41.00
9/16/2024TD CowenInitiated CoverageBuy
9/13/2024Jefferies Financial GroupInitiated CoverageBuy$40.00
9/4/2024WedbushInitiated CoverageOutperform$40.00
9/3/2024WedbushUpgradeStrong-Buy
 

Retire off just one stock ticker? (Ad)

ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now. They will NOT make you rich. However, there is one stock that stands head and shoulders above everything else. It's currently trading for only $15...

Click here for the ticker >>>